Panacea Index Logo

Command Palette

Search for a command to run...

Double-blind placebo and active (caffeine) controlled study to examine the effects of the herbal nutritional supplement beverage "Wake up" on vigilance and function after lunch.

The Israel Medical Association journal : IMAJ
August 1, 2013
Ola Kassis et al. (4 authors)
Comparative StudyControlled Clinical TrialJournal ArticleResearch Support, Non-U.S. Gov'tHuman StudyClinical
Study Details

Study Goal

The researchers aimed to assess whether caffeine (50 mg) and a herbal-based beverage ("Wake up") could counteract post-lunch somnolence and performance decline compared to a placebo.

Results Summary

Caffeine significantly improved alertness and performance 30 minutes post-consumption but led to performance deterioration and elevated blood pressure/pulse after 2 hours, unlike "Wake up," which maintained superiority over both caffeine and placebo at the 2-hour mark.

Population

30 healthy volunteers

Effective Dosage

50 mg caffeine (single dose)

Duration

Single-day intervention per condition (cross-over design)

Interactions

None mentioned

Extracted Claims (6)
InterventionDirectionEndpointPopulationDosageImpactClaim #
Wake up
increase
performance tests, subjective vigilance and effectiveness assessment
thirty healthy volunteers
-
significantly superior to placebo
#1
caffeine
increase
performance tests, subjective vigilance and effectiveness assessment
thirty healthy volunteers
-
significantly superior to placebo
#2
Wake up
increase
performance
thirty healthy volunteers
-
superior to both caffeine and placebo
#3
caffeine
decrease
performance
thirty healthy volunteers
-
performance had deteriorated
#4
caffeine
increase
blood pressure and pulse
thirty healthy volunteers
-
higher
#5
Wake up
no change
hemodynamic consequences
thirty healthy volunteers
-
no adverse hemodynamic consequences
#6
Abstract

BACKGROUND: Post-lunch dip is a well-known phenomenon that results in a substantial deterioration in function and productivity after lunch. OBJECTIVES: To assess whether a new herbal-based potentially wake-promoting beverage is effective in counteracting somnolence and reduced post-lunch performance. METHODS: Thirty healthy volunteers were studied on three different days at the sleep clinic. On each visit they ate a standard lunch at noontime, followed by a drink of "Wake up," 50 mg caffeine, or a placebo in a cross-over double-blind regimen. At 30 and 120 minutes post-drinking, they underwent a battery of tests to determine the effects of the beverage. These included: a) a subjective assessment of alertness and performance based on a visual analog scale, and b) objective function tests: the immediate word recall test, the digit symbol substitution test (DSST), and hemodynamic measurements. The results of the three visits were compared using one-way analysis of variance, with P < 0.05 considered statistically significant. RESULTS: In all performance tests, subjective vigilance and effectiveness assessment, both Wake up and caffeine were significantly superior to placebo 30 minutes after lunch. However, at 2 hours after lunch, performance had deteriorated in those who drank the caffeine-containing drink, while Wake up was superior to both caffeine and placebo. Blood pressure and pulse were higher 2 hours after caffeine ingestion, compared to both Wake up and placebo. CONCLUSIONS: These results suggest that a single dose of Wake up is effective in counteracting the somnolence and reduced performance during the post-lunch hours. In the current study it had no adverse hemodynamic consequences.

Medical Subject Headings (MeSH)
AdolescentAdultAnalysis of VarianceBeveragesBlood PressureCaffeineCognitionCross-Over StudiesDietary SupplementsDouble-Blind MethodFemaleHeart RateHumansLunchMaleMiddle AgedPlant ExtractsPostprandial PeriodPsychomotor PerformanceSleep StagesTime FactorsTreatment OutcomeWakefulnessYoung Adult
Study Links
PubMed ID24079062
Quality Scores
Safety70
Efficacy80/10
Quality85/10
Citation Metrics
Total Citations5
Citations/Year0.4
Relative Citation Ratio0.24
NIH Percentile12.2%
Research Impact Scores
APT Score0.25
Weight Score1.43
Normalized Score0.77
Related Supplements